Korean J Gastroenterol.  2021 May;77(5):227-230. 10.4166/kjg.2021.065.

How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease?  

• Kim MJ
• Hong SN
• Kim YH
• Choe YH

• KMID: 2516039
• DOI: http://doi.org/10.4166/kjg.2021.065

Abstract

With the increasing incidence of pediatric inflammatory bowel disease (IBD) in children and its impact throughout life, transition care has become an important issue. In Korea, no guidelines have been proposed to support the transition from the pediatric clinic to the adult IBD clinic. This paper reviews the current issues related to IBD patient care during the transition from pediatrics to adults to identify the barriers and critical elements for a successful transition. Thus far, a multi-disciplinary pediatric/adult clinic or alternate visits between pediatric and adult health care providers is the best model for pediatric to adult IBD clinics. Self-reliance and independence of patients with pediatric IBD are also essential for a successful transition. In addition, the timing of the transition from a pediatric clinic to an adult IBD clinic should not be determined because the issue is not the chronological age but rather the individual maturity.

Keyword

Inflammatory bowel diseases; Child; Adult; Transition to adult care

Reference

1. Blum RW, Garell D, Hodgman CH, et al. 1993; Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health. 14:570–576. DOI: 10.1016/1054-139X(93)90143-D.

2. Moon JS. 2019; Clinical aspects and treatments for pediatric inflammatory bowel diseases. Pediatr Gastroenterol Hepatol Nutr. 22:50–56. DOI: 10.5223/pghn.2019.22.1.50. PMID: 30671373. PMCID: PMC6333592.

3. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. 2011; Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 17:423–439. DOI: 10.1002/ibd.21349. PMID: 20564651.

4. Afzali A, Katz S. 2018; Inflammatory bowel disease in the baby to baby boomer: pediatric and elderly onset of IBD. Curr Treat Options Gastroenterol. 16:289–305. DOI: 10.1007/s11938-018-0188-9. PMID: 30006766.

5. Shim JO. 2019; Recent advance in very early-onset inflammatory bowel disease. Intest Res. 17:9–16. DOI: 10.5217/ir.2018.00130. PMID: 30419637. PMCID: PMC6361014.

6. Benchimol EI, Mack DR, Nguyen GC, et al. 2014; Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology. 147:803–e15. DOI: 10.1053/j.gastro.2014.06.023. PMID: 24951840.

7. Kang B, Kim JE, Jung JH, et al. 2020; Korean children and adolescents with Crohn's disease are more likely to present with perianal fistulizing disease at diagnosis compared to their European counterparts. Pediatr Gastroenterol Hepatol Nutr. 23:49–62. DOI: 10.5223/pghn.2020.23.1.49. PMID: 31988875. PMCID: PMC6966217.

8. Kim HJ, Oh SH, Kim DY, et al. 2017; Clinical characteristics and long-term outcomes of paediatric Crohn's disease: a single-centre experience. J Crohns Colitis. 11:157–164. DOI: 10.1093/ecco-jcc/jjw146. PMID: 27651220.

9. Kim J, Ye BD. 2019; Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key? Intest Res. 17:24–35. DOI: 10.5217/ir.2018.00128. PMID: 30419636. PMCID: PMC6361010.

10. Choi YJ, Lee DH, Shin DW, et al. 2019; Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study. Aliment Pharmacol Ther. 50:769–779. DOI: 10.1111/apt.15446. PMID: 31396984.

11. Axelrad JE, Lichtiger S, Yajnik V. 2016; Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 22:4794–4801. DOI: 10.3748/wjg.v22.i20.4794. PMID: 27239106. PMCID: PMC4873872.

12. Kumagai H, Suzuki Y, Shimizu T. 2021; Transitional care for patients with inflammatory bowel disease: Japanese experience. Digestion. 102:18–24. DOI: 10.1159/000510652. PMID: 33032280.

13. Baldassano R, Ferry G, Griffiths A, Mack D, Markowitz J, Winter H. 2002; Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 34:245–248. DOI: 10.1097/00005176-200203000-00001. PMID: 11964946.

14. van Rheenen PF, Aloi M, Biron IA, et al. 2017; European Crohn's and colitis organisation topical review on transitional care in inflammatory bowel disease. J Crohns Colitis. 11:1032–1038. DOI: 10.1093/ecco-jcc/jjx010. PMID: 28158494.

15. Kumagai H, Akiyama T, Abukawa D, et al. 2018; Guidelines for autonomy support of patients with IBD in the transitional period. Jpn J Pediatr Gastroenterol Hepatol Nutr. 32:15–27.

16. 2019. Jun. 3. Transitioning a patient with IBD from pediatric to adult care. [Internet]. The Children's Digestive Health & Nutrition Foundation;Flourtown (PA): Available from: https://www.naspghan.org/files/documents/pdfs/medicalresources/ibd/Checklist_PatientandHealthcareProdiver_TransitionfromPedtoAdult.pdf. cited 2021 Apr 10.

17. Nardone OM, Iacucci M, Ghosh S, Castiglione F. 2020; Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? Dig Liver Dis. 52:516–527. DOI: 10.1016/j.dld.2020.02.009. PMID: 32234418.

18. Kumagai H, Kudo T, Uchida K, et al. 2019; Adult gastroenterologists' views on transitional care: Results from a survey. Pediatr Int. 61:817–822. DOI: 10.1111/ped.13912. PMID: 31206932.

19. Tan B, Ong D. 2020; Pediatric to adult inflammatory bowel disease transition: the Asian experience. Intest Res. 18:11–17. DOI: 10.5217/ir.2019.09144. PMID: 32013311. PMCID: PMC7000639.

20. Gray WN, Holbrook E, Dykes D, Morgan PJ, Saeed SA, Denson LA. 2019; Improving IBD transition, self-management, and disease outcomes with an in-clinic transition coordinator. J Pediatr Gastroenterol Nutr. 69:194–199. DOI: 10.1097/MPG.0000000000002350. PMID: 30964817.

21. Kumagai H, Kudo T, Uchida K, et al. 2021; Transitional care for inflammatory bowel disease: a survey of Japanese pediatric gastroenterologists. Pediatr Int. 63:65–71. DOI: 10.1111/ped.14376. PMID: 32621773.

22. Goodhand J, Hedin CR, Croft NM, Lindsay JO. 2011; Adolescents with IBD: the importance of structured transition care. J Crohns Colitis. 5:509–519. DOI: 10.1016/j.crohns.2011.03.015. PMID: 22115368.

23. Sattoe JNT, Peeters MAC, Haitsma J, van Staa A, Wolters VM, Escher JC. 2020; Value of an outpatient transition clinic for young people with inflammatory bowel disease: a mixed-methods evaluation. BMJ Open. 10:e033535. DOI: 10.1136/bmjopen-2019-033535. PMID: 31911522. PMCID: PMC6955474.

24. Erős A, Soós A, Hegyi P, et al. 2020; Spotlight on transition in patients with inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 26:331–346. DOI: 10.1093/ibd/izz173. PMID: 31504524.

25. van den Brink G, van Gaalen MAC, de Ridder L, van der Woude CJ, Escher JC. 2019; Health care transition outcomes in inflammatory bowel disease: a multinational Delphi study. J Crohns Colitis. 13:1163–1172. DOI: 10.1093/ecco-jcc/jjz044. PMID: 30766997. PMCID: PMC7142327.